Multiple drug classes commonly prescribed for common medical conditions are capable of influencing the onset and progression of Alzheimer's disease, according to researchers at The Mount Sinai Medical Center. The findings ...
Jun 12, 2013
0
0
Although there are still some aspects pending confirmation for its use in the clinical setting, and its resolution needs to be improved slightly, a study by the UPV/EHU and Biobizkaia has shown that a method routinely used ...
Apr 19, 2024
0
36
Forgetfulness, lack of orientation, cognitive decline… about 700, 000 Germans suffer from Alzheimer's disease (AD). Now researchers from the University of Ulm, among them the Epidemiologist Professor Gabriele Nagel and ...
Sep 11, 2012
0
0
Disruptive clumps of mutated protein are often blamed for clogging cells and interfering with brain function in patients with the neurodegenerative diseases known as spinocerebellar ataxias. But a new study in fruit flies ...
Jan 31, 2014
0
0
Researchers at the Medical Research Council Toxicology Unit at the University of Leicester have identified a molecular mechanism that helps protect brain cells against a fall in core body temperature, which also appears to ...
Jan 15, 2015
0
45
A team of researchers grafting human spinal stem cells into rats modeled with amyotrophic lateral sclerosis (ALS), also known as "Lou Gehrig's Disease," a degenerative, lethal, neuromuscular disease, have tested four different ...
Dec 19, 2011
0
0
Amyloids—clumps of misfolded proteins found in the brains of people with Alzheimer's disease and other neurodegenerative disorders—are the quintessential bad boys of neurobiology. They're thought to muck up the seamless ...
Apr 3, 2013
1
0
A new imaging technique developed at MIT offers the first glimpse of the degeneration of two brain structures affected by Parkinson's disease.
Nov 26, 2012
0
1
(HealthDay)—In patients with type 2 diabetes, retinal sensitivity is associated with cognitive status, according to a study published in the September issue of Diabetes.
Oct 31, 2017
0
2
Researchers at the University of Minnesota's Center for Drug Design have developed a synthetic compound that, in a mouse model, successfully prevents the neurodegeneration associated with Alzheimer's disease.
Dec 3, 2012
0
0
